Skip to main content

Home/ Pharmaceutical Laboratory/ Group items tagged IT

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
hamelinclara

20 hospitals with inspiring social media strategies | Articles | Home - 0 views

www.prdaily.com/...ial_media_strategie_10655.aspx

hospital social_media

shared by hamelinclara on 22 Apr 13 - No Cached
  • 1. Mayo Clinic The Mayo Clinic has long been an online resource for medical information, with a website that offers advice and expertise from more than 3,300 medical professionals for free, so it’s not at all surprising that the medical group has been successful in social media
  • Doctors were able to share and connect with readers and patients through a first-hand account of relief efforts performed after the 2010 Haiti earthquake.
  • Massachusetts General Hospital recognizes this, and did something amazing when researchers from the Emergency Department worked together to create an iPhone app designed to help users find the closest emergency room to their area anywhere in the U.S. The app was promoted using hospital social media outlets, creating a YouTube video that bloggers could embed in their stories, also providing for opportunities to tweet the video and share it on Facebook. With the help of social media, the hospital’s app was able to stand out in the sea of apps available for the iPhone.
  • ...17 more annotations...
  • During the Ft. Hood shooting crisis, one of the hospitals treating victims, Scott & White, took it upon themselves to share updates with the community. Employee Steven Widman offered updates on emergency room access, hospital operation status, and more, also updating with Red Cross news and sharing communications with reporters. The crisis pushed Scott & White’s communications to the forefront of social media, increasing their Twitter followers by 78 percent in only three days, turning Scott & White Healthcare into a Twitter "trending topic," and ranking the hospital’s YouTube channel among the most viewed non-profit channels during the crisis. Both people who were affected and those who were tuned in from afar were able to get real-time updates, thanks to the efforts of Widman and the ability of social media to share information.
  • Nebraska Medical Center has created an incredible YouTube presence, one so successful, that as 360 Digital Influence points out, they’ve had an increase in requests for one surgery in particular. It’s all thanks to a patient who shared her cancer experience on YouTube, which led to so many requests for the surgery she had to treat her rare carcinoid cancer that NMC had to open a monthly clinic for the condition. The medical center encourages patients to share their experience, and even makes use of QR codes to share videos of physicians introducing themselves to potential patients.
  • Connecting with patients and community members is great, but what if you could use social media to do something really amazing, like raise more than $1 million for a new children’s hospital? UCSF did just that, taking on a social media fundraising contest named Challenge for the Children. About 165,000 people blew past the hospital’s initial $100,000 fundraising goal thanks to social media channels including Facebook and Twitter. Much of the campaign’s success ($805,554 worth) was thanks to the Facebook game FarmVille, which allowed players to purchase virtual candy cane seeds that sent 100 percent of the profits to the challenge. This amazingly successful challenge paved the way for a new children’s hospital in Mission Bay, set for completion in 2014, and the top two teams will be honored with the naming of a dedicated space in the hospital.
  • t’s so important to be relevant to the topic at hand in social media, and getting off course can turn off would-be fans. But WakeMed Health & Hospitals in Raleigh, North Carolina made a smart move in April 2011, sharing a time-lapse video shot from the hospital’s helipad that showed a tornado as it passed through the area. Although the tornado is a non-medical story not directly related to the hospital’s mission, hospitals are a vital part of any community, and in sharing this video, WakeMed further cemented itself as a valuable resource for the Raleigh area. Med City News praised WakeMed for the video, pointing it out as one of the top blog entries for the medical group. As WakeMed spokeswoman Heather Monackey shares, they’ve found success in social media because they "just pay attention to what’s going on."
  • Hospitals are using social media to connect internally, in addition to community building. At Texas Health Resources, social media tools make it possible for physicians and other health professionals to engage with each other and take advantage of useful tools. Using social media, Texas Health Resources promotes the adoption of electronic health records, and integrates the use of the private microblogging site Yammer to share internal messages, how-to videos, and more. Project managers and physicians use social media tools like Yammer to come together, collaborate, and communicate effectively over a large hospital system.
  • ealth care social media isn’t just about attracting patients and building community, at least not for Geisinger Health System in Danville, Pennsylvania. The health system typically turned to ads in medical journals and direct mail to recruit gastroenterologists, but when they had trouble getting enough responses, associate vice president of marketing Cathy Connolley turned to social media to recruit their physicians. With the help of a recruitment marketing firm, Geisinger created a social media physician recruitment campaign, creating a convenient and cost-effective way to communicate with physicians, and an easy way to direct gastroenterologists to their Facebook page. As Connolley reports, "that tactic outpaced our direct mail approach and our email blasts."
  • Live-tweeting brain surgery just sounds like crazy talk, but Henry Ford Hospital near Detroit made it work. While performing surgery on a 47-year-old man, doctors discussed the procedure with more than 1,900 people, and even uploaded video of the surgery to YouTube. Things seem to go to the next level when the answer to Twitter’s "What are you doing?" question is brain surgery. The hospital earned praise and attention from ABC News, and showed off just how well they can make use of social media. In addition to Twitter brain surgeries, Henry Ford Hospital makes use of news feeds, Flickr, and blogging to reach patients and the general community.
  • Scripps makes it a point to connect with patients and customers through the use of social media. In an interview with Found In Cache, Scripps director of web technology Marc Needham shared that the hospital typically spends its social media time on customer service. In fact, Scripps developed a new position of Electronic Customer Service Representative, specifically created to reach out to patients through social media and respond to online reviews. Needham pointed out that Scripps believes it’s important to have a good handle on their online brand perception, and left unchecked, "unaddressed complaints fester and lead to online reputation rot." Scripps has found success in this pursuit, but Needham says they haven’t quite defined their social media approach just yet, and they’re still experimenting with a variety of different sites, including Wikipedia, YouTube, Flickr, Facebook, and LinkedIn. Scripps tends to use different sites for different purposes, like Facebook for recruitment and LinkedIn for employee connections.
  • hildren’s Hospital Boston has a wildly popular Facebook page. A Facebook page alone isn’t quite enough to be truly impressive these days, but Children’s Hospital Boston really stands out, not just for its half a million plus fans, but really for its top-notch content. Their landing page has information people really want to read, and an encouraging atmosphere that gets patients and fans to open up and share their stories. This high level of engagement is truly inspiring, and offers a great lesson for any Facebook Page owner. Through photos of the week, Children’s Hospital Boston highlights families and patients, who in turn spread the word to their friends and family on Facebook, bringing fans and patients to the Facebook Page to interact. But, as Ignite Social Media points out, Children’s Hospital Boston does so much more than Facebook, effectively managing a Twitter feed and YouTube video collection as well.
  • arasota Memorial Hospital understands the value to building better relationships through social media. In an interview with The Side Note, the hospital’s market research manager Shawn Halls shared how it came to begin using social media as an important tool. After growth and more than three years of use, Sarasota Memorial now sees Twitter and other sites as an important part of their communications strategy, using social media as a way for the community to directly communicate with the hospital. The hospital encourages patients to direct message their Twitter account, and has even been able to connect patient family members with resources like local florists through the site. Like other hospitals, Sarasota Memorial also has plans to share surgery via Twitter, specifically a brain mapping procedure where the patient is awake.
  • Social media is great for spreading news, but it’s also a useful tool for correcting misinformation as well. The Greater Baltimore Medical Center knows that fact all too well, as in August 2010, a Baltimore TV station incorrectly reported that the hospital had been invaded by an armed robber. GBMC media relations manager Michael Schwartzberg was able to act quickly to correct the mistake, sending out a swift collection of tweets that set the story straight for the public and concerned citizens. With active social media accounts already in place, the foundation for sharing information was set and easy to take advantage of, something that the hospital utilizes frequently. Schwartzberg reports that in addition to media relations and customer service, GBMC uses social media as a valuable way to share crisis communication, much like their fake armed robber, H1N1 updates, and if need be, disaster reporting.
  • Just like GBMC, Inova Health found value in Twitter’s ability to set incorrect information straight. Inova uses a security system designed to prevent the theft of babies from maternity wards, and as hospital personnel ran a test of the system, a visitor heard it and mistakenly believed that there was a lost baby. That same visitor then tweeted about the non-incident. Director of digital communications and marketing Chris Boyer had wisely set up social media monitoring services, and quickly spotted the tweet within just minutes of posting. After calling to confirm that there was not actually a problem, Boyer was able to immediately respond on Twitter and share the hard facts of the story, helping to preserve the hospital’s reputation before things got really crazy. Inova Health’s story shows just how important it is to use tools that can help you monitor and stay on top of your social media presence.
  • Living organ donation is an amazing gift and process, and Children’s Medical Center was able to share a special family’s story through Twitter. As a Texas firefighter donated his kidney to his three-year-old son, the Twitterverse was able to follow along with their successful story from start to finish, shared by none other than the mom and wife. With nearly 85,000 people on the waiting list for a kidney, Children’s Medical Center media relations manager Jessica Newell hopes that "twittering from this surgery will help raise awareness for organ donation, as well as living organ donation."
  • Twitter and social media in general can be a scary thing for hospitals, opening up issues of liability and uncomfortable situations. But at least at the University at Buffalo School of Medicine and Biomedical Sciences, doctors and professors recognize Twitter as an incredibly valuable tool for learning and training. Dr. Philip L. Glick shares his insight: "[A] lot of the training consists of passing on information, lessons learned, and wisdom to the next generation. Twitter allows us to dramatically scale up our ability to do this. When I post something on Twitter, all the pediatric surgeons, trainees and colleagues in the country and the world can see it instantly." In addition to small updates, University at Buffalo uses social media to share audio and video of procedures, breaking them down into small pieces that offer opportunities for sharing and teaching. 18. St. Luke’s Cedar Rapids
  • Anxious groups of families and friends sit in hospital waiting rooms across the country, hoping to hear updates and news that their loved one is doing well. Some will find out about things as they go along, some simply when procedures are over. The level of information shared largely depends on the capacity and availability of the team of medical professionals at work. With Twitter, the time and energy necessary to share updates with loved ones is significantly decreased, and small, frequent updates can be shared in just moments, creating an opportunity for hospitals to better inform worried waiting rooms as things go along. At St. Luke’s Cedar Rapids, one family was able to enjoy this incredible level of customer service, as their 70-year-old mother Monna Cleary underwent a hysterectomy and uterine prolapse surgery. Cleary had given her OK for the hospital to share a play-by-play of her operation, and hospital spokeswoman Sarah Corizzo shared more than 300 tweets, allowing the family to follow along, and informing the general public. Corizzo answered questions, and fascinated nearly 700 people who followed along with the surgery. Hospital spokeswoman Laura Rainey pointed out that live-tweeting is a "more gentle" way to inform patients and consumers, allowing them to follow what’s going on without shocking visuals. Cleary’s son Joe and his siblings appreciated the opportunity, pointing out that "it made the time go by," and they enjoyed having real-time information and staying informed while in the waiting room.
  • haring information during a crisis is vital, even when you don’t have a lot of time or resources to do it. So when more than 50 people had to go to hospitals for treatment following a chemical fume exposure at a trash disposal station, Southcoast Hospital turned its Twitter account into a "crisis communication portal," sharing status updates for more than a week. Updates included status on admitted, discharged, and treated patients during the spill, and helpful information and links that kept the public and concerned loved ones constantly updated during the situation.
  • Hospitals are full of stories that the community is interested in, with people overcoming great odds and going on to live healthier lives. At Barnes-Jewish Hospital, a 23-year-old heart transplant patient Megan Moss attracted lots of local interest, thanks to updates from the Barnes-Jewish Hospital blog, Touching Base. Additionally, Megan’s dad shared constant updates through his own blog. Moss’s story attracted so much attention, that one weekend, she got 75 emails through the hospital’s website with well wishes from friends, family, and strangers alike. Through numerous updates and even a video interview with the hospital’s director of heart transplant, both Moss and Barnes-Jewish got much deserved attention within the community.
hamelinclara

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It - Seeking Alpha - 0 views

seekingalpha.com/...-little-pharma-can-do-about-it

pharma 2013 Biotechnologies costs

shared by hamelinclara on 13 Feb 13 - No Cached
  • Most of these costs, writes the author Avik Roy, have to do with one specific aspect of the pipeline - phase III
  • Overall, Phase III trials now represent about 40 percent of pharmaceutical companies' R&D expenditures.
  • Phase III trials have become bigger, more complicated, more restrictive, and more time consuming as the years pass. Why should this be so? Is medical technology really getting all that more complicated that progressively more restrictive phase III trials are the only thing standing between global health and a renegade pharmaceutical industry intent on poisoning the human race with wildly experimental drugs?
  • ...4 more annotations...
  • two primary reasons
  • While bureaucrats get a thrill regulating, Big Pharma encourages it. Think about it this way.
  • Three of the most generous also happen to have the most pipeline drugs in phase III this year: Novartis (NVS), Roche (RHHBY.OB), and Sanofi-Aventis (SNY).
  • Let's start with Novartis. Novartis' last dividend was a very generous $2.48 per share annually. That's 4.6% per share since last dividend, and totals over $6B in dividends, which was an impressive 62% of its 2012 income. It spent close to $7B (page 50) in research and development costs in 2012, with around 20 drugs (pages 32-35) currently in phase III trials. No small cap would be able to afford such largesse, but that number is only 12% of its annual revenue. With government keeping out competition and subsidizing consumption, Novartis is sailing the corporatist sweet spot. At least it is nominally returning the favor to its shareholders with a dividend large enough to offset the risk of holding a stock that is near its all-time highs.Roche comes up right behind Novartis with 19 drugs in the pipeline at the all-expensive Phase III. It spent a similar amount of money on R&D as Novartis did at a hefty $8B, which was about 17% of its 2011 revenue. RHHBY is at a similar juncture as NVS. Nearing all-time highs and sailing in the same protected sweet spot. At a $1.84 dividend it is also quite generous with its shareholders, totaling 4.27% per share annually, a total amount of $6.355B forked over to shareholders, which totals just under 60% of its 2012 income, just shy of Novartis'.
hamelinclara

Pharma industry's most productive innovators recognised - 0 views

ideapharma.com/...oductive-innovators-recognised

industry pharma

shared by hamelinclara on 13 Feb 13 - No Cached
  • This year there were two major factors which contributed to Johnson & Johnson’s number one ranking. It successfully brought to market Abiraterone (Zytiga) - a lyase and steroid synthesis inhibitor for use in the treatment of prostate cancer - and furthermore it was a major riser in the Access to Medicine Index, which is of increasing global importance.”
  • “Roche, which kept its number 3 spot on the Index, saw the first combined launch of a drug and companion diagnostic device, but on the negative side it had to close phase III development of dalcetrapib, a potentially $20bn product. “Sanofi, although rising one place to rank fifth, suffered a massive climbdown with Zaltrap in colorectal cancer launching at a suicidally high price which it continued to defend against increasing criticism. It eventually cut costs to 50 per cent but the damage had been done. “And AstraZeneca is the perfect example of a company which has shown all the signs of panic over the past five years. The stress of an underwhelming pipeline has led it to make bad decisions on top of bad decisions, and although it enjoyed some top line growth by flogging its sales model, the same primary care sales model has led to poor decisions in many areas.”
hamelinclara

'OK Glass, Save A Life.' The Application Of Google Glass In Sudden Cardiac Death - Forbes - 0 views

www.forbes.com/...glass-in-sudden-cardiac-arrest

google_glass

shared by hamelinclara on 18 Aug 13 - No Cached
  • hamelinclara on 18 Aug 13
     
    "Google GOOG -0.32% Glass has made its way into healthcare.  Its use in the operating room and in medical education has been profiled here.  Yet the magic of Glass will be found in the applications that can make this "technology" into real-world solutions for health and medicine.  It's a bit like the smart phone and how its realization is a function of the countless apps that bring the device to life. Inside The Operating Room With Google Glass John Nosta Contributor Christian Assad, MD has taken the next step with Glass and developing a practical app that can turn Glass into a real life-saver. He recently profiles this application on his blog and I believe it's an important turn of events that showcase just how technology can be applied to medicine and public health issues.  Here's how it presents the concept in his blog-Google Glass and augmented CPR:"
hamelinclara

Is Pinterest the Risk-Free Social Channel for Pharma? - 0 views

blog.pharmexec.com/...free-social-channel-for-pharma

pinterest

shared by hamelinclara on 14 Jul 13 - No Cached
  • hamelinclara on 14 Jul 13
     
    "I recently came across a blog post headlining Pinterest as the "safest place" for medical marketers to start with social media. All too aware that there are many Pharma marketers out there still a little shy of social, it was a must read. Launched just three years ago, Pinterest has enjoyed phenomenal expansion of its user base, posting growth of 1,000 percent in 2012. As of June 2013 it had more than 48 million users, generating 2.5 billion page views a month. With a demographic skewed heavily towards 25 to 34 year-old women, half of them with children, the potential for marketers seems real. If you're not sure exactly what Pinterest is, imagine a huge virtual pinboard where users display pictures they like. Users can pin up their own images, but mostly they pin images from other people's websites or re-pin images previously posted on Pinterest - 80 percent of the images on Pinterest have been re-pinned, or shared, within the network. It's this re-pinning that makes Pinterest interesting for brands - the opportunity to harness the viral power of social sharing is enormous. In a recent adoption rates study, social media analytics firm Simply Measured reported that 69 percent of the Interbrand top 100 brands are on Pinterest."
hamelinclara

Selling Science Smartly: Pfizer's "More Than Medication" Campaign « ScriptPhD - 0 views

www.scriptphd.com/...-more-than-medication-campaign

shared by hamelinclara on 29 Nov 12 - No Cached
  • The cleverness of CP+B’s “More Than Medication” campaign is 50% in the content that’s there, and 50% in the content that isn’t. Missing are the saccharine smiles, ridiculous athletic feats and idyllic dalliances of perfectly healthy people that never took the medication they’re purporting to be endorsing. Rather than portraying people who could be anyone (or, sadly, no one), these ads are the antithesis. “More Than Medication” is about life—mundane, radiant, lifechanging, heartbreaking. Through all of these milestones, Pfizer is attempting to build relationships one person at a time, and be a valuable presence in their healthy lives at their most important stages. Only time will tell if the campaign pays dividends, but as advertising strategy, it’s brilliant. Pharmaceutical companies rely on wholescale batch assembly at every stage of development, from searching for molecules as drug candidates, to researching them, to the mass production thereof. In fact, the fermentation tanks developed by Pfizer that enabled the first-ever mass production of penicillin during World War II became a national historic landmark in 2008. This doesn’t dictate that pharmaceutical ads must follow the same standard operating protocol.
  • Beyond “reinventing” pharmaceutical advertising, the “More Than Medication” campaign taps into an important (and growing) wellness zeitgeist being embraced by the professional and private health care sectors. Within the last few years, emphasis has shifted significantly from medication to meditation, pills to pilates, and technology to tofu. Individual preventitive care, including eating habits, exercise, healthfulness beyond chemicals, and individual responsibility, has been gaining momentum as a critical component of modern medicine, nowhere more than in how it is advertised. Kaiser Permanente’s enormously successful and popular “Thrive” campaign, recently expanded to the tune of $53 million, has echoes the welness call to arms of Canada’s “More Than Medication” spots. Internal documents indicate that the 2004 campaign was launched to combat a declining membership of 150,000 in a similarly reviled industry (health insurance). The initially modest reach has since expanded to print, outdoors, television and radio.
  • Pfizer supplemented their television spots with an interactive website that offers resources for individuals and their families, including eating better, strengthening mind and body, practical life tips, and places to find help to achieve these goals. In doing do, the pharmaceutical behemoth rebrands themselves as in touch, personally connected on an individual level and convey that they care about their patients’ health even if it means never having to take one of their medications.
  • ...3 more annotations...
  • The client wanted to create a bond of trust with consumers. Research showed that consumers don’t trust drug companies, and believe that they put profits before people. In Canada, we also have health care system issues with limited physician access and pressure on doctors to spend less time with patients. Canadians feel powerless when it comes to their health. We knew that in order for Pfizer to build trust, we had to show Canadians that Pfizer’s point of view was different from other pharmaceutical companies; that, as a company, they believe that wellness is not achieved by taking pills, but about a more holistic, balanced approach that doesn’t require any of their drugs at all. “More Than Medication” was the freshest and clearest expression of our core idea. It takes a lot of people by surprise that a pharma company would take such a stance.
  • e couldn’t let the work we did reinforce any of the negative perceptions of the pharma industry. We took the completely opposite tack to traditional pharma campaigns which typically focus on research and innovation and how that benefits people. Ultimately, those messages don’t resonate because they are company focused, not people focused. To break through, Pfizer had to shed all of the baggage and aim for a more insightful, emotional high ground which no other pharma company has done, even to this day.
  • “More than medication” is more than a campaign – it’s a mantra that has positively impacted how Pfizer behaves as an organization. It’s been culture shifting for them. Externally, it has raised brand scores across a variety of metrics, trust being one of the
  • hamelinclara on 29 Nov 12
     
    the food one
hamelinclara

E-HEALTH LEARNING EXPEDITION -DAY 1 (with image... - 0 views

www.scoop.it/e-health-start-ups

Start-up ehealth

shared by hamelinclara on 23 Apr 13 - No Cached
  • Et quoi de plus beau que de faire ce voyage sous le signe d'UMANLIFE ?https://www.umanlife.com/
  • Depuis le début de l'année...Umanlife s'est illustrée ...Start-up Award à Pharmasuccess, 1er prix de la start up Academy..et je vous épargne la revue de presse tant elle est fournie désormais. J'ai rencontré Umanlife et son fondateur Alexandre Plé il y a près d'un an...j'ai tout de suite été séduit par le concept.
  • commencer par ce SCOOP IT... déjà plus de 300 articles sur le sujet du voyage....tous tagués !Vous pouvez donc utiliser les options de FILTRAGE en haut pour vous intéresser aux informations sur une société en particulier.... Pour tout savoirAbonnez vous à ce scoop it...http://www.scoop.it/t/e-health-start-upsVenez liker PHARMAGEEKhttps://www.facebook.com/Pharmageeket UMANLIFEhttps://www.facebook.com/umanlifeEt surtout...PRENEZ VOTRE VIE EN MAIN:https://www.umanlife.com/
hamelinclara

Success at The End of The Patent Cliff: How High Performing Pharma Companies Are Prepar... - 1 views

social.eyeforpharma.com/...pharma-patent-cliff-new-normal

patent success pharma stratégies

shared by hamelinclara on 22 Jan 13 - No Cached
  • Anne O’Riordan, Global Industry Managing Director of Accenture’s Life Sciences group, believes that this offers an engine for return to growth.Moody’s Credit Outlook agree and in response they have upgraded their outlook for the Pharmaceutical Sector from Negative to Stable, pointing out that “the multiyear wave of drug patent expirations that have squeezed profits should subside next year”.
  • Global pharmaceutical company GlaxoSmithKline has been hugely successful at supporting a culture of innovation with smaller entrepreneurial units as well as developing strengths in the consumer health markets in the Middle East and Asia.
  • Bristol-Meyers Squibb has also developed a very specific strategy and targeted unmet clinical needs, such as biological dugs and oncology, as well as executed some creative deals with big pharma companies and implemented fundamental internal organisational changes.
  • ...5 more annotations...
  • Novartis, in the face of the loss of patent protection on its top selling pharmaceutical, has managed to weather the patent cliff storm because of two key factors: the development of innovative drugs and its diversity in holding other business interests, with over-the-counter and vaccine business delivering a major portion of their growth this year.
  • positive about what is happening in the pharma sector and believe there is a growing portion of non-patent cliff expose revenues within this group: “We are increasingly seeing investor interest in the pharma group shifting to longer-term growth prospects/pipeline expectations as the sector moves beyond its 2012/2013 patent cycle”.
  • Roche has been doing some of their own research and see no major threat from patent expiration. They are comforted by the fact that US patents for some of their most successful oncology drugs are safe until 2016 and that the full market development of competitive drugs is unlikely to really kick in until 2015 due to factors such as complicated approval processes. In addition, this company is spending around 50 percent of total R&D on its oncology pipeline, which they believe will deliver significant returns.
  • Success requires the commitment and discipline to have a clear strategy and be decisive about where a company can focus and remain visible. In addition, it is critical to build new capabilities so emerging markets are readily identified, expedient product launches are delivered, R&D is undertaken collaboratively and multichannel marketing is put into practice.
  • ere are companies exhibiting a discipline for change and investors are rewarding them for that. So don’t lose sight of fact that there are plenty of opportunities for growth going forward”
hamelinclara

Socializing Pharma - Sanofi Gets it Right - 0 views

www.sam-welch.com/...ng-pharma-sanofi-gets-it-right

sanofi diabetes ehealth

shared by hamelinclara on 20 Apr 13 - No Cached
  • hamelinclara on 20 Apr 13
     
    "Socializing Pharma - Sanofi Gets it Right"
hamelinclara

If I Were A Big Pharma Head Of R&D... - Forbes - 0 views

www.forbes.com/...2

enjeux

shared by hamelinclara on 11 Aug 13 - No Cached
  • hamelinclara on 11 Aug 13
     
    "Some of these ideas might be unworkable on a practical basis, but the spirit of where they are trying to steer the R&D organization of the future is clear: a healthier culture that is both more entrepreneurial and empowered to take risks, and less encumbered by legacy baggage and short-termist thinking.  With its deep bench of experienced talent, huge resources, cutting-edge capabilities, and unparalleled global development and downstream footprint, Big Pharma should be well positioned to drive biomedical research and innovation. And there are select examples of that happening today. But collectively as an industry it's not able to unlock this potential - recoding its cultural DNA may hold the key."
hamelinclara

Will Novartis Change the Pharmaceutical Industry? | Wall St. Cheat Sheet - 0 views

wallstcheatsheet.com/...e-pharmaceutical-industry.html

pharma

shared by hamelinclara on 10 Jan 13 - No Cached
  • As the company’s business has been hit hard by the loss of patent protection for one of its key drugs, the high blood pressure treatment Diovan, and the financial pressures affecting healthcare systems worldwide, Novartis has begun to change the method it uses to price its medicines
  • I … started to shift our business away from a transactional model that was focused on physically selling the drugs to delivering an outcome-based approach to add value beyond just the pill,” said Jimenez in an interview with The Wall Street Journal. “I really believe that in the future, companies like Novartis are going to be paid on patient outcomes as opposed to selling the pill.”
hamelinclara

Five questions with Mayo Clinic social media chief Lee Aase | MedCity News - 0 views

medcitynews.com/...ic-social-media-chief-lee-aase

Start-up interview mayo ehealth

shared by hamelinclara on 22 Apr 13 - No Cached
  • Social media is no longer used just for marketing purposes
  • “These tools aren’t just about building market shares, but they’re about helping patients and connecting providers,” he said.
  • n the next few weeks, Mayo will roll out another mobile app to connect patients with its online community. But its priority from now until February, according to Aase, will be promoting heart health through a social media campaign called “Know Your Numbers,” launched this morning at the conference. It combines a YouTube video, a Facebook app and a contest to raise awareness leading up to American Heart Month.
hamelinclara

Pharma's Most Productive Innovators: The Top Ten - 0 views

blog.pharmexec.com/...ductive-innovators-the-top-ten

industry pharma

shared by hamelinclara on 13 Feb 13 - No Cached
  • “AstraZeneca is the perfect example of a company which has shown all the signs of panic over the past five years,” said Rea. “The stress of an underwhelming pipeline has led it to make bad decisions on top of bad decisions, and although it enjoyed some top line growth by flogging its sales model, the same primary care sales model has led to poor decisions in many areas.”
hamelinclara

China bypasses Big Pharma patents, authorizes low-cost generic drug manufacturing - 0 views

www.naturalnews.com/_China_Big_Pharma_patents.html

shared by hamelinclara on 29 Nov 12 - No Cached
  • The Chinese government has officially amended its patent laws to allow drug companies to reproduce generic, low-cost versions of expensive
  • China is considering further strengthening its legal framework, so as to make use of legal space to produce generic drugs
hamelinclara

Understanding new influences acting on healthcare practitioners: Gaining a 360-degree v... - 0 views

www.ngpharma.com/...a-360-degree-view-of-customers

shared by hamelinclara on 29 Nov 12 - No Cached
  • healthcare practitioners (HCPs)
  • 1. Managed care-driven2. Patient-driven3. Technology-driven
  • The following questions are being tested in industry research to better characterize the new influences and to set up more insightful metrics of brand performance: How does the influence affect the strength of the relationship between the prescriber, company, and brand?  Can relationships with HCPs be strengthened by indirect influences, such as social media?  Regular assessment of relationship strength and corresponding value delivered is critical for brands operating under new commercial models. How does the influence support or contradict the brand's value proposition?  One metric to consider is believability of the brand's message in light of new influences being exercised. For example, peer-to-peer experiential dialog via the Internet may substantiate or significantly weaken the brand's claims. A metric of "customer alignment" is required and can be quantified by mining the dialog. To what extent does the influence help or hurt company communication and education efforts, including personal promotion?  The emergence of widely accessible technologies for sharing information has the potential to spread incomplete, biased, or worse, inaccurate information, which may change the nature of discussions between reps and HCPs. Field organizations must understand and address misconceptions and objections that develop more quickly in today's highly-connected environment. At the heart of today's influences are two related goals: containing costs and understanding comparative effectiveness. Measurement programs need to consider both these drivers to effectively evaluate brand performance. Measuring the impact of a pharmaceutical
  • ...5 more annotations...
  • brand on patient outcomes and cost containment is still in its infancy as a commercial business practice. However, new metrics about cost and value are taking shape, even if they are not yet on the brand's balanced scorecard or performance dashboard. A good starting point for using new metrics is to assign them only to new influences initially. They could then be expanded to traditional promotion and education activities.
  • Penetration: increase in the number of active presribers of the brand   Treatment Rates: increase in patients diagnosed and treated Disease Intervention Rates: decrease in the time to assess and treat first-line failures Patient Compliance/Adherence: increase in patient compliance with regimen
  • The first step is expanding (or at least re-deploying) resources for measuring the extent of HCP exposure to influence sources and the resulting behavioral change. Commercial analytics teams can begin by creating an influence map indicating the corresponding sources of data available
  • As a second step, brand managers should look for gaps between the findings and their brand strategy and promotion plans. Within the brand plan, it is helpful to include a list of major influences acting on HCPs and to plan a set of programs against these influences. Each year, the brand plan should have a few promotional "R&D" elements that offer more insight into the impact of new influences and how well the brand team is addressing them.
  • Once influences are identified, prioritized, and included in the brand plan for observation and future action, the third step-tracking and assessing impact-can begin. This involves adding a few Key Performance Indicators (KPIs) such as brand penetration, productivity, and adherence on the brand dashboard to monitor the spread of the influence, and to track how well the brand is responding to these influences.
hamelinclara

Paying the price | DAWN.COM - 0 views

dawn.com/...paying-the-price

shared by hamelinclara on 20 Jan 13 - No Cached
  • Price freeze or not, it is true that prices of medicine have increased over the years and often the consumer ends up paying double the original price to a retailer, due to shortage. Manufacturers and market players put the blame on each other for shortage knowing that there won’t be any action from the government
  • While keeping a price freeze for many years, the government has been allowing price surges to the manufacturers under hardship cases.
  • He states that it is natural that pharma companies slow down the manufacture of a product on which they are incurring losses or barely breaking even
hamelinclara

Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines -- PHILAD... - 1 views

www.prnewswire.com/...f-new-medicines-170329346.html

Pharma Research TransCelerate

shared by hamelinclara on 09 Jan 13 - No Cached
  • Ten leading biopharmaceutical companies announced today that they have formed a non-profit organization to accelerate the development of new medicines. Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech a member of the Roche Group, and Sanofi launched TransCelerate BioPharma Inc. ("TransCelerate"), the largest ever initiative of its kind, to identify and solve common drug development challenges with the end goals of improving the quality of clinical studies and bringing new medicines to patients faster.
  • financial and other resources, including personnel, to solve industry-wide challenges in a collaborative environment.
  • among the heads of R&D at major pharmaceutical companies that there is a critical need to substantially increase the number of innovative new medicines,
  • ...2 more annotations...
  • As shared solutions in clinical research and other areas are developed, TransCelerate will involve industry alliances including Clinical Data Interchange Standards Consortium (CDISC), Critical-Path Institute (C-Path), Clinical Trials Transformation Initiative (CTTI), Innovative Medicines Initiative (IMI), regulatory bodies including the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), and Contract Research Organizations (CROs).
  • "We applaud the companies in TransCelerate BioPharma for joining forces to address a series of longstanding challenges in new drug development. This collaborative approach in the pre-competitive arena, utilizing the collective experience and resources of 10 leading drug companies and others to follow, has the promise to lead to new paradigms and cost savings in drug development, all of which would strengthen the industry and its ability to develop innovative and much-needed therapies for patients.
hamelinclara

Drug Makers Join Efforts in Research - NYTimes.com - 1 views

www.nytimes.com/...rt-to-streamline-research.html

TransCelerate

shared by hamelinclara on 09 Jan 13 - No Cached
  • One project would be to standardize the way data from clinical trials are recorded. That would make it easier for clinical trial investigators to enter data without having to remember each company’s format and to compare data from clinical trials. Similarly, TransCelerate will work on a common Internet portal that investigators can use to communicate with all drug companies, and also on standardizing efforts to qualify clinical trial sites and to train investigators. It will also work on a way for companies to easily procure one another’s already marketed drugs for use in comparative clinical trials.
1 - 20 of 34 Next ›
Showing 20▼ items per page